On 2/22/2024, Evolent Health (EVH) reported earnings of $0.15 per share on revenue of $556.06 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.02 per share on revenue of $542.39 million.
On the 4-hour chart the trend started on August 29 (linear regression channel).
There is a high probability of profit taking. Possible take profit level is 30.08
But we should not forget about SL = 24.64
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am very interested in it. Thank you!
Good luck!
Regards, ...
On the hour chart the trend started on August 7 (linear regression channel).
There is a high probability of profit taking. Possible take profit level is 30.65
But we should not forget about SL = 27.71
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am very interested in it. Thank you!
Good luck!
Regards, WeBelieveInTrading
1. ER disaster & Bounce and roll structure
2. break volume POC
3. MA congestion
4. Lower high and reversal at high. Cannot break 50MA
Also note the negative vol profile
Fundamental peaked. Next year earning negative and decreasing but PE still high, may need to catch up to the downside.
This could be an example of price leading the fundamental, where the...
Price is below support line.
Oversold.
Price remains above the .382 of the trend up.
Earning's date conflicts, but is early November.
No recommendation.
EPS (FWD)
0.40
PE (FWD)
75.93
Div Rate (TTM)
Short Interest
7.88%
Market Cap
$2.95B
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative...
Primary buy on EVH
I like how it wedge pops and pulls above GLB on same day . GLB marked in green line .
Lets see if it works out .
Entry 34.74
Stop 33.60
PT 1 - 36.02 , sell 1/4 , stop up
PT 2 - 37.23
Breaking out of one month consolidation. Constructive price and volume action and a market leader.
You don't need to know what's going to happen next to make money ~Mark Douglas
Lose like a pro and keep trading, or lose like a novice and quit ~Mark Ritchie
watching for break past 35.76 for all time high breakout confirmation, after that we can target 40-49-59
rejection from this area can send it 21-25 area though! trade carefully
EVH getting closer to a breakout
10 Month Long Base
Trading above 200DMA
Volume on higher side
Institutional Ownership: 97%
Institutional Transaction Last 3 Months: 2.5%
Measured Target: 47.50
$EVH is one on close watch that I would like to own.
Big cup with handle base that goes back to October of last year.
The handle is taking on a head and shoulders bottoming pattern and a mini coil forming today to boost.
Lots to like here.
Looking to take this trade for about 20% upside. I have a loose stop loss but earning are pretty good. Been away from the desk for awhile. Back to some trades.
Poor valuation on this company. It is not worth $3 billion market cap. Short put strategy naked put on technical indicators makes this a good investment. This stock will be going down.
We all come here to notice that Walgreens is not interested in the Merger with EVH after digging into the company earnings and realizing there's a conflict of interest in proprietary technology. A Merger makes no sense any more spokesman said. "We'd like to notify private investors today to let them know that the deal doesn't seem to fit our model anymore as far...
WAC 15% HIGH EVolve ROIC -4% . Many people are speaking about a merger, this suggestion is a misnomer as why would a bullish running company catored to the Software industry be under merger talks? With who?
WACC% 15.48 ROIC -3.73 Operating Margin -4.18 Net Margin -7.28 ROE -11.23 ROA -5.35 3 Year EPS NRI Growth Rate -61.20 Net Income Operations -72.27 70%...
Evolent Health Inc Cl A Com (EVH)
WBA is in talks with Evolent to buy its healthcare industry peer. Citing "people familiar with the matter," Bloomberg pointed out that Evolent is experiencing pressure from activist investor Engaged Capital to consider a sale, among other "value creation" measures.
The target price could be $35.20
GoodLuck
